Victory Capital Management
EW icon

Victory Capital Management’s Edwards Lifesciences EW Stock Holding History

Victory Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.2M Buy
214,242
+1,122
+0.5% +$92.5K 0.01% 925
2025
Q4 		$18.2M Buy
213,120
+7,868
+4% +$646K 0.01% 887
2025
Q3 		$16M Sell
205,252
-2,326
-1% -$182K 0.01% 949
2025
Q2 		$16.2M Sell
207,578
-8,384
-4% -$625K 0.01% 946
2025
Q1 		$15.7M Sell
215,962
-1,563
-0.7% -$112K 0.02% 898
2024
Q4 		$16.1M Sell
217,525
-6,030
-3% -$422K 0.02% 928
2024
Q3 		$14.8M Sell
223,555
-12,393
-5% -$900K 0.01% 960
2024
Q2 		$21.8M Sell
235,948
-6,640
-3% -$588K 0.02% 781
2024
Q1 		$23.2M Buy
242,588
+12,783
+6% +$1.07M 0.02% 758
2023
Q4 		$17.5M Sell
229,805
-2,924
-1% -$203K 0.02% 828
2023
Q3 		$16.1M Buy
232,729
+15,877
+7% +$1.28M 0.02% 828
2023
Q2 		$20.5M Sell
216,852
-17,585
-8% -$1.53M 0.02% 766
2023
Q1 		$19.4M Sell
234,437
-6,862
-3% -$539K 0.02% 797
2022
Q4 		$18M Sell
241,299
-383,806
-61% -$29.6M 0.02% 813
2022
Q3 		$51.7M Buy
625,105
+12,937
+2% +$1.24M 0.06% 441
2022
Q2 		$58.2M Buy
612,168
+302,932
+98% +$31.4M 0.07% 415
2022
Q1 		$32.7M Buy
309,236
+21,652
+8% +$2.43M 0.03% 700
2021
Q4 		$37.3M Sell
287,584
-1,641
-0.6% -$191K 0.03% 671
2021
Q3 		$32.7M Sell
289,225
-10,657
-4% -$1.22M 0.03% 700
2021
Q2 		$31.1M Sell
299,882
-3,966
-1% -$374K 0.03% 740
2021
Q1 		$25.4M Sell
303,848
-749,464
-71% -$63.4M 0.03% 814
2020
Q4 		$96.1M Sell
1,053,312
-28,986
-3% -$2.4M 0.11% 272
2020
Q3 		$86.4M Sell
1,082,298
-99,029
-8% -$7.73M 0.11% 246
2020
Q2 		$81.6M Sell
1,181,327
-1,075,117
-48% -$76.4M 0.11% 255
2020
Q1 		$142M Buy
2,256,444
+763,821
+51% +$55.1M 0.12% 238
2019
Q4 		$116M Sell
1,492,623
-173,991
-10% -$13.6M 0.14% 190
2019
Q3 		$122M Buy
1,666,614
+815,733
+96% +$57.3M 0.16% 165
2019
Q2 		$52.4M Buy
850,881
+167,670
+25% +$10.1M 0.11% 288
2019
Q1 		$43.6M Sell
683,211
-321,723
-32% -$18.4M 0.1% 321
2018
Q4 		$51.3M Sell
1,004,934
-46,197
-4% -$2.34M 0.13% 230
2018
Q3 		$61M Sell
1,051,131
-6,429
-0.6% -$314K 0.13% 241
2018
Q2 		$51.3M Sell
1,057,560
-35,967
-3% -$1.68M 0.11% 295
2018
Q1 		$50.9M Sell
1,093,527
-170,853
-14% -$7.42M 0.11% 286
2017
Q4 		$47.5M Sell
1,264,380
-408,939
-24% -$15M 0.1% 321
2017
Q3 		$61M Buy
1,673,319
+73,197
+5% +$2.79M 0.14% 230
2017
Q2 		$63.1M Buy
1,600,122
+10,662
+0.7% +$389K 0.15% 220
2017
Q1 		$49.8M Sell
1,589,460
-379,395
-19% -$11.9M 0.12% 300
2016
Q4 		$61.5M Buy
1,968,855
+907,203
+85% +$29.4M 0.16% 225
2016
Q3 		$42.7M Buy
1,061,652
+367,461
+53% +$13.8M 0.12% 289
2016
Q2 		$23.1M Sell
694,191
-32,394
-4% -$1.11M 0.09% 375
2016
Q1 		$21.4M Buy
726,585
+6,567
+0.9% +$181K 0.09% 390
2015
Q4 		$19M Sell
720,018
-504,294
-41% -$13.1M 0.08% 404
2015
Q3 		$29M Buy
1,224,312
+1,200,204
+4,978% +$29M 0.12% 302
2015
Q2 		$576K Buy
+24,108
New +$544K ﹤0.01% 968
2013
Q4 		– Sell
-342
Closed -$3K – 975
2013
Q3 		$3K Buy
+342
New +$4K ﹤0.01% 1237

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Victory Capital Management's EW Position: Q1 2026 in Review

Victory Capital Management increased its Edwards Lifesciences (EW) stake by 0.53% in Q1 2026, buying an estimated $92.5K and bringing the position to 214,242 shares worth $17.2M. The position accounts for 0.01% of the portfolio, ranked #925.

Victory Capital Management first reported a position in EW in Q3 2013 and has held it in 45 quarters since. The position peaked at $142M in Q1 2020. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Victory Capital Management held 214,242 shares of Edwards Lifesciences worth $17.2M as of Q1 2026.
  • Victory Capital Management bought 1,122 Edwards Lifesciences shares in Q1 2026, an estimated $92.5K.
  • Edwards Lifesciences made up 0.01% of Victory Capital Management's portfolio in Q1 2026, its #925 holding.
  • Victory Capital Management first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 45 quarters since.
  • Victory Capital Management's Edwards Lifesciences position peaked at $142M in Q1 2020.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.